Ctc Bio, Incorporation. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ctc Bio, Incorporation. with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 118.10 billion Korean Won [US$104.87 million]
of which 59%
was Environment Material),
(144.44 billion Korean Won [US$128.26 million]
CKD Bio Corp
(118.19 billion Korean Won [US$104.95 million]
of which 100%
was Pharmaceutical Manufacturing).
Ctc Bio, Incorporation. reported sales of 130.56 billion Korean Won (US$115.94 million)
December of 2017.
increase of 6.0%
versus 2016, when the company's sales were 123.15 billion Korean Won.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Ctc Bio, Incorporation. had sales
of 129.78 billion Korean Won.
Sales of Hay saw an increase
that was more than double the company's growth rate: sales were up
30.1% in 2017, from
29.48 billion Korean Won to 38.35 billion Korean Won.
Not all segments of Ctc Bio, Incorporation. experienced an increase in sales in 2017:
sales of Human Medication fell 11.6% to 1.83 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).
Ctc Bio, Incorporation. also experienced decreases in sales in
Animal Medication (down 1.5% to 92.19 billion Korean Won)